Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: Possible explanation for iron overload

Journal of Hepatology

Volumn 24, Issue 5, 1996, Pages 564-569

  Fargion, Silvia ^a,e   Fracanzani, Anna Ludovica ^a   Romano, Riccardo ^a   Cappellini, Maria Domenica ^a   Faré, Maristella ^b   Mattioli, Michela ^a   Piperno, Alberto ^c   Ronchi, Guido ^d   Fiorelli, Gemino ^a  

^a Inst Int Med Med Physiopathology   (Italy)

^b ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^c Institute of Biomedical Sciences   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Duodenal ferritin; Genetic hemochromatosis; HLA A3; Iron overload; Porphyria cutanea tarda

Indexed keywords

FERRITIN; HLA A3 ANTIGEN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

EID: 0029903136     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80141-3     Document Type: Article

References (43)

1. Felsher BF, Kushner JP. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect. Semin Hematol 1977; 14: 243-51.
2. Lundvall O, Weinfeld A, Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand 1970; 188: 37-53.
3. Felsher BF, Norris ME, Shin JC. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda. N Engl J Med 1982; 306: 766-9.
4. De Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea tarda: two different diseases. Hum Genet 1978; 44: 145-51.
5. Cohen PR, Deleo VA. Disorders of porphyrin metabolism. In: Alper JC, ed. Genetic Disorders of the Skin. Chicago: Year Book Medical Publishers, 1990: 79-104.
6. Elder GH, Urquhart AJ, De Salamanca RE, Munoz JJ, Bonkovsky HL. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1985; i: 229-32.
7. Hindmarsh JT. Enzyme heterogeneity in the porphyria. Clin Biochem 1990; 23: 371-4.
8. Haberman HF, Rosemberg L, Menon LA. Porphyria cutanea tarda: comparison cases precipitated by alcohol and estrogens. Can Med Assoc J 1975; 113: 633-55.
9. Nip-Sakamoto CJ, Wong RHW, Izumi AK. Porphyria cutanea tarda and AIDS. CUTIS 1989; 44: 470-1.
10. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-6.
11. Lundvall O. The effect of phlebotomy therapy in porphyria cutanea tarda. Acta Med Scand 1971; 189: 33-49.
12. Kushner JP, Edwards CQ, Dadone MM, Skolnick MH. Heterozygosity for HLA-linked hemochromatosis as a likely cause of hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology 1985; 88: 1232-8.
13. Elder GH. Porphyria cutanea tarda and HLA-linked hemochromatosis. Gastroenterology 1985; 88: 1276-9.
14. Beaumont C, Fauchet R, Phung LN, Verneuil HD, Gueguen M, Nordmann. Porphyria cutanea tarda and HLA-linked Hemochromatosis. Gastroenterology 1987; 92: 1833-8.
15. Edwards CQ, Griffen LM, Kushner JP. Increased frequency of HLA-A3 in subjects with sporadic porphyria cutanea tarda. Tissue Antigens 1988; 31: 250-1.
16. Adams PC, Powell LW. Porphyria cutanea tarda and HLA-linked hemochromatosis- all in the family? Gastroenterology 1987; 92: 2033-5.
17. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62.
18. Hallberg L, Bjorn Rasmussen E, Jungmer I. Prevalence of hereditary hemochromatosis in two Swedish urban areas. J Intern Med 1989; 225: 249-55.
19. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of hemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525-30.
20. Velati C, Piperno A, Fargion S, Colombo S, Fiorelli G. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Haematologica 1990; 75; 309-12.
21. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW eds. Iron Metabolism in Health and Disease. London, Philadelphia, Toronto, Sydney, Tokyo: Saunders Company Ltd, 1994; 227-70.
22. Fracanzani AL, Fargion S, Romano R, Piperno A, Arosio P, Ruggeri G, Ronchi G, Fiorelli G. Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. Gastroenterology 1989; 96: 1071-8.
23. Scheuer PG, Williams R, Muiz AR Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 1962; 84: 53-64.
24. Barry M, Sherlock S. Measurement of liver iron concentration in needle biopsy specimens. Lancet 1971; i: 100-3.
25. Elder GH, Lee GB, Tovey JA. Decrease activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 1978; 299: 274-8.
26. Iron Panel of the International Committee for Standardization in Haematology. The measurement of total and unsaturated iron- binding capacity in serum. Br J Haematol 1978; 38: 281-90.
27. Iron Panel of the International Committee for Standardization in Haematology. Recommendations for measurement of serum iron in human blood. Br J Haematol 1978; 38: 291-4.
28. Edwards Q, Griffin LM, Skolnick MH, Kushner JP. Sporadic porphyria cutanea tarda in individuals with HLA-linked hemochromatosis allele(s). In: Weintraub LR, Edwards CQ, Krikker M, eds. Hemochromatosis. Proceedings of the First International Conference. Ann NY Acad Sci 1988; 526: 47-53.
29. Seymour DG, Elder GH, Fryer A, Jacobs A, Williams GT. Porphyria cutanea tarda and haemochromatosis: a family study. Gut 1990; 31: 719-21.
30. Dadone MM, Khusner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Pathol 1982; 78: 196-297.
31. Deugnier Y, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102:2050-9.
32. Panajotopoulos N, Piperno A, Conte D, Mandelli C, Cesana M, Mercuriali F, Fiorelli G, Bianchi PA, Fargion S. HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives. Tissue Antigens 1989; 33: 431-6.
33. Simon M, LE Mignon L, Fauchet R, Yaouanq J, David V, Edan G, Bourel M. A study of 609 HLA haplotypes marking for the hemochromatosis gene: 1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and 2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 1987; 41: 89-105.
34. Reizenstein P, Hoglund S, Landegren J, Carlmark B, Forsberg K. Iron metabolism in porphyria cutanea tarda. Acta Med Scand 1975; 198:95-9.
35. Pietrangelo A, Rocchi E, Rigo G, Ferrari AL, Perini M, Ventura E, Cairo G. Regulation of transferrin, transferrin receptor and ferritin gene expression in the duodenum of normal, anemic and siderotic subjects. Gastroenterology 1992; 102: 802-9.
36. Pietrangelo A, Gualdi R, Casalgrandi G, Conte D, Cesarini L, Ventura E, Cairo G. Molecular defects in the control of duodenal iron metabolism in genetic hemochromatosis. Gastroenterology 1993; 104: A272.
37. Lundin L, Hallgren R, Birgegard G, Wide L. Serum ferritin in alcoholics and the relation to liver damage, iron state and erythropoietic activity. Acta Med Scand 1981; 209:327-31.
38. Di Bisceglie AM, Constantine AA, Hoofnagle JH, Bacon BR. Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-13.
39. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to interferon a therapy is influenced by the iron content of the liver. J Hepatol 1994; 20:410-5.
40. Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 1995; 22:268-71.
41. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655-9.
42. Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani AL, Vecchi L, Failla M, Fiorelli G. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992; 16: 364-8.
43. Beard P, Offord E, Paduwat N, Bruggmann H. SV40 activates transcription from transferrin receptor promoter by inducing a factor which binds to the CRE/AP-1 recognition sequence. Nucl Acid R 1991; 19: 7117-23.